Altered CVD Risk in Transgender Adults Undergoing Hormone Therapy
Cardiovascular disease risk factors may be altered among transgender adults receiving cross-sex hormone therapy (CSHT).
Cardiovascular disease risk factors may be altered among transgender adults receiving cross-sex hormone therapy (CSHT).
Only 28% of young MSM have HIV testing, although they account for 83% of new diagnoses.
Public health professionals need to pay attention to this vulnerable population, researchers say.
Dr Sara Gianella talks with Brooke Sullivan, a transgender woman and HIV activist, about ways to improve transgender individuals’ involvement in HIV research.
Dr Sara Gianella talks with Dr Sheldon Morris, from the University of California San Diego AntiViral Research Center about an upcoming PrEP study in transgender people.
The rise is attributed to more widespread insurance coverage and growing acceptance of transgender people.
Nearly 15% of all gay men report dealing with anorexia or bulimia during their lifetime.
Elderly LGBTQ individuals are more likely to be depressed and have poor general health than non-LGBTQ seniors.
However, ER providers expected most patients to refuse to provide this information.
Although there were increased hemoglobin, hematocrit, BMI and lower HDL levels seen with testosterone use.